Alan Rong
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 15
- Colorectal Cancer Treatments and Studies 14
- Cancer Treatment and Pharmacology 3
-
- Statistical Methods in Clinical Trials 10
- Co-authors
- Kelly S. Oliner (4 shared papers)Jennifer Gansert (3 shared papers)Yevhen Hotko (3 shared papers)Michel Ducreux (3 shared papers)Florian Lordick (3 shared papers)Thierry André (3 shared papers)Andrés Cervantes (3 shared papers)Marc Peeters (5 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Journal of Biopharmaceutical Statistics (4 papers)Pharmaceutical Statistics (4 papers)Statistics in Medicine (2 papers)Annals of Oncology (2 papers)
- Partner nations
- United StatesBelgiumFrance
In The Last Decade
Alan Rong
26 papers receiving 1.0k citations
Alan Rong's Hit Papers
Peers
Comparison fields: 5 of 77
- Oncology 732
- Hepatology 155
- Pathology and Forensic Medicine 184
- Statistics and Probability 93
- Cancer Research 128
Countries citing papers authored by Alan Rong
This map shows the geographic impact of Alan Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Rong more than expected).
Fields of papers citing papers by Alan Rong
This network shows the impact of papers produced by Alan Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Rong. The network helps show where Alan Rong may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Rong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer Hit paper breakdown → | 2010 | 756 |
| 2 | 2015 | 45 | |
| 3 | 2013 | 42 | |
| 4 | 2015 | 38 | |
| 5 | 2013 | 37 | |
| 6 | 2009 | 23 | |
| 7 | 2018 | 20 | |
| 8 | Randomized Phase 3 Study of Panitumumab With FOLFIRI vs. FOLFIRI Alone as Second-Line Treatment in Patients With Metastatic Colorectal Cancer | 2010 | 18 |
| 9 | 2021 | 13 | |
| 10 | 2018 | 10 | |
| 11 | 2021 | 8 | |
| 12 | 2018 | 7 | |
| 13 | 2020 | 4 | |
| 14 | 2017 | 4 | |
| 15 | 2015 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2022 | 2 | |
| 18 | 2013 | 2 | |
| 19 | 2015 | 2 | |
| 20 | Chromothripsis in Uterine Leiomyomas | 2013 | 2 |
About Alan Rong
Alan Rong is a scholar working on Oncology, Statistics and Probability, Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 28 papers that have together received 1.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (14 papers), Statistical Methods in Clinical Trials (10 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Genomics and Diagnostics (5 papers), Optimal Experimental Design Methods (4 papers), Cancer Treatment and Pharmacology (3 papers), Biosimilars and Bioanalytical Methods (3 papers) and Genetic factors in colorectal cancer (3 papers). The work is most often cited by research in Oncology (732 citations), Hepatology (155 citations), Pathology and Forensic Medicine (184 citations), Statistics and Probability (93 citations) and Cancer Research (128 citations). Alan Rong has collaborated with scholars based in United States, Belgium and France. Frequent co-authors include Kelly S. Oliner, Jennifer Gansert, Yevhen Hotko, Michel Ducreux, Florian Lordick, Thierry André, Andrés Cervantes, Marc Peeters, Timothy Price and Emily Chan. Their work appears in journals such as Journal of Clinical Oncology, Journal of Biopharmaceutical Statistics, Pharmaceutical Statistics, Statistics in Medicine and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.